A Study of MK-6213 Co-Administered With Atorvastatin in Participants With Hypercholesterolemia (MK-6213-006)

NCT00687271 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

334

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: MK-6213
DRUG: Atorvastatin calcium
DRUG: Placebo for MK-6312 160 mg
DRUG: Placebo for Atorvastatin 20 mg

Sponsor

Merck Sharp & Dohme LLC